Amedeo Smart

Free Medical Literature Service



HIV Infection

  Free Subscription


1 AIDS Res Hum Retroviruses
1 Am J Epidemiol
16 Clin Infect Dis
1 Curr Treat Options Neurol
1 HIV Med
4 J Acquir Immune Defic Syndr
2 J Immunol
5 J Infect Dis
1 J Med Virol
7 J Virol
4 Lancet HIV
1 Lancet Public Health
1 MMWR Morb Mortal Wkly Rep
3 N Engl J Med
1 Nature
1 Neurology
1 Pediatr Infect Dis J
1 PLoS Comput Biol
2 PLoS Med
12 PLoS One
3 PLoS Pathog
1 Proc Natl Acad Sci U S A


  1. Soluble CD163 predicts incident chronic lung, kidney and liver disease in HIV infection: Erratum.
    AIDS. 2018;32:679.
    >> Share

  2. OLDENBURG CE, Chanda MM, Ortblad KF, Mwale M, et al
    Effect of HIV self-testing on the number of sexual partners among female sex workers in Zambia.
    AIDS. 2018;32:645-652.
    >> Share

  3. POIZOT-MARTIN I, Laroche H, Cano CE, Nicolino-Brunet C, et al
    Cancer risk in HIV-infected patients: elite controllers are also concerned.
    AIDS. 2018;32:673-675.
    >> Share

  4. ISMAIL MF, Wong DK, Bogoch II
    The role for hepatitis A vaccination in HIV pre-exposure prophylaxis.
    AIDS. 2018;32:675-676.
    >> Share

  5. Immunodeficiency, AIDS-related pneumonia, and risk of lung cancer among HIV-infected individuals: Erratum.
    AIDS. 2018;32:681.
    >> Share

  6. Reducing HIV infection in people who inject drugs is impossible without targeting recently-infected subjects: Erratum.
    AIDS. 2018;32:685.
    >> Share

    AIDS Res Hum Retroviruses

  7. HENNINK M, Kaiser B, Marconi V
    Pathways to Retention in HIV Care among US Veterans.
    AIDS Res Hum Retroviruses. 2018 Feb 28. doi: 10.1089/AID.2017.0201.
    >> Share

    Am J Epidemiol

  8. LAMA JR, Brezak A, Dobbins JG, Sanchez H, et al
    Design Strategy of the Sabes Study: Diagnosis and Treatment of Early HIV Infection Among Men Who Have Sex With Men and Transgender Women in Lima, Peru, 2013-2017.
    Am J Epidemiol. 2018 Mar 7. pii: 4924563. doi: 10.1093.
    >> Share

    Clin Infect Dis

  9. RUSIE LK, Orengo C, Burrell D, Ramachandran A, et al
    PrEP Initiation and Retention in care over five years, 2012-2017: Are quarterly visits too much?
    Clin Infect Dis. 2018 Mar 1. pii: 4915901. doi: 10.1093.
    >> Share

  10. FORD N, Shubber Z, Jarvis JN, Chiller T, et al
    CD4 Cell Count Threshold for Cryptococcal Antigen Screening of HIV-Infected Individuals: A Systematic Review and Meta-analysis.
    Clin Infect Dis. 2018;66.
    >> Share

  11. SIIKA A, McCabe L, Bwakura-Dangarembizi M, Kityo C, et al
    Late Presentation With HIV in Africa: Phenotypes, Risk, and Risk Stratification in the REALITY Trial.
    Clin Infect Dis. 2018;66.
    >> Share

  12. POST FA, Szubert AJ, Prendergast AJ, Johnston V, et al
    Causes and Timing of Mortality and Morbidity Among Late Presenters Starting Antiretroviral Therapy in the REALITY Trial.
    Clin Infect Dis. 2018;66.
    >> Share

  13. OSLER M, Hilderbrand K, Goemaere E, Ford N, et al
    The Continuing Burden of Advanced HIV Disease Over 10 Years of Increasing Antiretroviral Therapy Coverage in South Africa.
    Clin Infect Dis. 2018;66.
    >> Share

  14. FORD N, Meintjes G, Calmy A, Bygrave H, et al
    Managing Advanced HIV Disease in a Public Health Approach.
    Clin Infect Dis. 2018;66.
    >> Share

  15. CALMY A, Ford N, Meintjes G
    The Persistent Challenge of Advanced HIV Disease and AIDS in the Era of Antiretroviral Therapy.
    Clin Infect Dis. 2018;66.
    >> Share

  16. SEKAGGYA-WILTSHIRE C, von Braun A, Lamorde M, Ledergerber B, et al
    Delayed Sputum Conversion in TB-HIV Co-Infected Patients with Low Isoniazid and Rifampicin Concentrations.
    Clin Infect Dis. 2018 Mar 3. pii: 4919550. doi: 10.1093.
    >> Share

  17. MUTOH Y, Nishijima T, Inaba Y, Tanaka N, et al
    Incomplete Recovery of CD4 count, CD4 Percentage, and CD4/CD8 ratio in HIV-Infected Patients on Long-Term Antiretroviral Therapy with Suppressed Viremia.
    Clin Infect Dis. 2018 Mar 2. pii: 4917726. doi: 10.1093.
    >> Share

  18. FRIGATI L, Archary M, Rabie H, Penazzato M, et al
    Priorities for Decreasing Morbidity and Mortality in Children With Advanced HIV Disease.
    Clin Infect Dis. 2018;66.
    >> Share

  19. LETENDRE S, Bharti A, Perez-Valero I, Hanson B, et al
    Higher Anti-CMV IgG Concentrations are Associated with Worse Neurocognitive Performance During Suppressive Antiretroviral Therapy.
    Clin Infect Dis. 2018 Mar 1. pii: 4915913. doi: 10.1093.
    >> Share

  20. OUSLEY J, Niyibizi AA, Wanjala S, Vandenbulcke A, et al
    High Proportions of Patients With Advanced HIV Are Antiretroviral Therapy Experienced: Hospitalization Outcomes From 2 Sub-Saharan African Sites.
    Clin Infect Dis. 2018;66.
    >> Share

  21. CARMONA S, Bor J, Nattey C, Maughan-Brown B, et al
    Persistent High Burden of Advanced HIV Disease Among Patients Seeking Care in South Africa's National HIV Program: Data From a Nationwide Laboratory Cohort.
    Clin Infect Dis. 2018;66.
    >> Share

  22. TRAEGER MW, Schroeder SE, Wright EJ, Hellard ME, et al
    Effects of Pre-exposure Prophylaxis for the Prevention of HIV Infection on Sexual Risk Behavior in Men Who Have Sex with Men: A Systematic Review and Meta-analysis.
    Clin Infect Dis. 2018 Mar 2. pii: 4917600. doi: 10.1093.
    >> Share

  23. KLEINSTEIN SE, Shea PR, Stamm LM, Sulkowski M, et al
    Association of CYP2B6 Single-Nucleotide Polymorphisms Altering Efavirenz Metabolism With Hepatitis C Virus (HCV) Treatment Relapse Among Human Immunodeficiency Virus/HCV-Coinfected African Americans Receiving Ledipasvir/Sofosbuvir in the ION-4 Trial.
    Clin Infect Dis. 2018 Mar 7. pii: 4705930. doi: 10.1093/cid/cix1051.
    >> Share

  24. MOGALIAN E, Stamm LM, Osinusi A, Brainard DM, et al
    Drug-Drug Interactions Studies between HCV Antivirals Sofosbuvir/Velpatasvir and Boosted and Unboosted HIV Antiretroviral Regimens in Healthy Volunteers.
    Clin Infect Dis. 2018 Mar 7. pii: 4924529. doi: 10.1093.
    >> Share

    Curr Treat Options Neurol

  25. DAVIS A, Meintjes G, Wilkinson RJ
    Treatment of Tuberculous Meningitis and Its Complications in Adults.
    Curr Treat Options Neurol. 2018;20:5.
    >> Share

    HIV Med

  26. RYOM L, Boesecke C, Bracchi M, Ambrosioni J, et al
    Highlights of the 2017 European AIDS Clinical Society (EACS) Guidelines for the treatment of adult HIV-positive persons version 9.0.
    HIV Med. 2018 Mar 1. doi: 10.1111/hiv.12600.
    >> Share

    J Acquir Immune Defic Syndr

  27. NALINTYA E, Meya DB, Lofgren S, Hullsiek KH, et al
    A Prospective Evaluation of a multisite Cryptococcal Screening and Treatment program in HIV clinics in Uganda.
    J Acquir Immune Defic Syndr. 2018 Mar 2. doi: 10.1097/QAI.0000000000001669.
    >> Share

  28. WOOLS-KALOUSTIAN K, Marete I, Ayaya S, Sohn AH, et al
    Time to First-Line ART Failure and Time to Second-Line ART Switch in the IeDEA Pediatric Cohort.
    J Acquir Immune Defic Syndr. 2018 Mar 2. doi: 10.1097/QAI.0000000000001667.
    >> Share

  29. PATHELA P, Jamison K, Braunstein SL, Schillinger JA, et al
    Gaps along the HIV care continuum: findings among a population seeking sexual health care services in New York City.
    J Acquir Immune Defic Syndr. 2018 Mar 2. doi: 10.1097/QAI.0000000000001674.
    >> Share

  30. SPITTAL PM, Malamba SS, Ogwang MD, Musisi S, et al
    Cango Lyec (Healing the Elephant): Gender differences in HIV infection in post-conflict Northern Uganda.
    J Acquir Immune Defic Syndr. 2018 Mar 2. doi: 10.1097/QAI.0000000000001671.
    >> Share

    J Immunol

  31. RAHMAN MA, McKinnon KM, Karpova TS, Ball DA, et al
    Associations of Simian Immunodeficiency Virus (SIV)-Specific Follicular CD8(+) T Cells with Other Follicular T Cells Suggest Complex Contributions to SIV Viremia Control.
    J Immunol. 2018 Mar 5. pii: jimmunol.1701403. doi: 10.4049/jimmunol.1701403.
    >> Share

  32. KUMAR V, Mansfield J, Fan R, MacLean A, et al
    miR-130a and miR-212 Disrupt the Intestinal Epithelial Barrier through Modulation of PPARgamma and Occludin Expression in Chronic Simian Immunodeficiency Virus-Infected Rhesus Macaques.
    J Immunol. 2018 Mar 7. pii: jimmunol.1701148. doi: 10.4049/jimmunol.1701148.
    >> Share

    J Infect Dis

  33. STEFIC K, Novelli S, Mahjoub N, Seng R, et al
    Non-reactive HIV-1 Rapid Tests after Sustained Viral Suppression Following Antiretroviral Therapy Initiation During Primary Infection.
    J Infect Dis. 2018 Mar 2. pii: 4917573. doi: 10.1093.
    >> Share

  34. VOLZ EM, Le Vu S, Ratmann O, Tostevin A, et al
    Molecular Epidemiology of HIV-1 Subtype B Reveals Heterogeneous Transmission Risk: Implications for Intervention and Control.
    J Infect Dis. 2018 Feb 26. pii: 4915980. doi: 10.1093.
    >> Share

    Risk of HIV Acquisition during Pregnancy and Postpartum: A Call for Action.
    J Infect Dis. 2018 Feb 28. pii: 4913312. doi: 10.1093.
    >> Share

    Amplifying the Population Health Benefits of PrEP for HIV Prevention.
    J Infect Dis. 2018 Feb 26. pii: 4915988. doi: 10.1093.
    >> Share

  37. THOMSON KA, Hughes J, Baeten JM, John-Stewart G, et al
    Increased Risk of Female HIV-1 Acquisition Throughout Pregnancy and Postpartum: A Prospective Per-coital Act Analysis Among Women with HIV-1 Infected Partners.
    J Infect Dis. 2018 Mar 5. pii: 4915924. doi: 10.1093.
    >> Share

    J Med Virol

  38. GAO L, Wang Y, Li Y, Dong Y, et al
    Genome-wide expression profiling analysis to identify key genes in the anti-HIV mechanism of CD4(+) and CD8(+) T cells.
    J Med Virol. 2018 Mar 6. doi: 10.1002/jmv.25071.
    >> Share

    J Virol

  39. SHI J, Xiong R, Zhou T, Su P, et al
    HIV-1 Nef antagonizes SERINC5 restriction by downregulation of SERINC5 via the endosome/lysosome system.
    J Virol. 2018 Mar 7. pii: JVI.00196-18. doi: 10.1128/JVI.00196.
    >> Share

  40. HESSELL AJ, Shapiro MB, Powell R, Malherbe DC, et al
    Reduced cell-associated DNA and improved viral control in macaques following passive transfer of a single anti-V2 monoclonal antibody and repeated SHIV challenges.
    J Virol. 2018 Mar 7. pii: JVI.02198-17. doi: 10.1128/JVI.02198.
    >> Share

  41. PANASIUK M, Rychlowski M, Derewonko N, Bienkowska-Szewczyk K, et al
    Tunneling nanotubes (TNT) as a novel route of cell-to-cell spread of herpesviruses.
    J Virol. 2018 Feb 28. pii: JVI.00090-18. doi: 10.1128/JVI.00090.
    >> Share

  42. KRISTENSEN AB, Kent SJ, Parsons MS
    Contribution of NK cell education to both direct and anti-HIV-1 antibody-dependent NK cell functions.
    J Virol. 2018 Mar 7. pii: JVI.02146-17. doi: 10.1128/JVI.02146.
    >> Share

  43. HUAN C, Li Z, Ning S, Wang H, et al
    Long non-coding RNA uc002yug.2 activates HIV-1 latency through regulating mRNA level of various RUNX1 isoforms and increasing Tat expression.
    J Virol. 2018 Feb 28. pii: JVI.01844-17. doi: 10.1128/JVI.01844.
    >> Share

  44. CARNATHAN DG, Mackel JJ, Sweat SL, Enemuo CA, et al
    Intragastric administration of Lactobacillus plantarum and AT-2-inactivated SIV does not protect Indian rhesus macaques from intra-rectal SIV challenge nor reduce virus replication after transmission.
    J Virol. 2018 Feb 28. pii: JVI.02030-17. doi: 10.1128/JVI.02030.
    >> Share

  45. ASHOKKUMAR M, Aralaguppe SG, Tripathy SP, Hanna LE, et al
    Unique phenotypic characteristics of recently transmitted HIV-1 subtype C envelope glycoprotein gp120: Use of CXCR6 co-receptor by transmitted founder viruses.
    J Virol. 2018 Feb 28. pii: JVI.00063-18. doi: 10.1128/JVI.00063.
    >> Share


  46. LABHARDT ND, Ringera I, Lejone TI, Klimkait T, et al
    Effect of Offering Same-Day ART vs Usual Health Facility Referral During Home-Based HIV Testing on Linkage to Care and Viral Suppression Among Adults With HIV in Lesotho: The CASCADE Randomized Clinical Trial.
    JAMA. 2018 Mar 6. pii: 2674479. doi: 10.1001/jama.2018.1818.
    >> Share

  47. KATZ IT, Ehrenkranz P, El-Sadr W
    The Global HIV Epidemic: What Will It Take to Get to the Finish Line?
    JAMA. 2018 Mar 6. pii: 2674478. doi: 10.1001/jama.2018.2093.
    >> Share

    Lancet HIV

  48. TUCKER JD, Fenton KA
    Innovation challenge contests to enhance HIV responses.
    Lancet HIV. 2018;5:e113-e115.
    >> Share

    Shared goals for tuberculosis and HIV.
    Lancet HIV. 2018;5:e107.
    >> Share

  50. NOSTLINGER C, Loos J
    Migration patterns and HIV prevention in Uganda.
    Lancet HIV. 2018 Feb 23. pii: S2352-3018(18)30023.
    >> Share

  51. OLAWORE O, Tobian AAR, Kagaayi J, Bazaale JM, et al
    Migration and risk of HIV acquisition in Rakai, Uganda: a population-based cohort study.
    Lancet HIV. 2018 Feb 23. pii: S2352-3018(18)30009.
    >> Share

    Lancet Public Health

  52. PANNETIER J, Ravalihasy A, Lydie N, Lert F, et al
    Protecting female migrants from forced sex and HIV infection.
    Lancet Public Health. 2018;3:e112.
    >> Share

    MMWR Morb Mortal Wkly Rep

  53. EVANS ME, Labuda SM, Hogan V, Agnew-Brune C, et al
    Notes from the Field: HIV Infection Investigation in a Rural Area - West Virginia, 2017.
    MMWR Morb Mortal Wkly Rep. 2018;67:257-258.
    >> Share

    N Engl J Med

  54. GOTTLIEB GS, Raugi DN, Smith RA
    HIV Drug Resistance.
    N Engl J Med. 2018;378:874-5.
    >> Share

  55. BERTAGNOLIO S, Jordan MR, Doherty M
    HIV Drug Resistance.
    N Engl J Med. 2018;378:874.
    >> Share

  56. INZAULE SC, Rinke de Wit TF, Hamers RL
    HIV Drug Resistance.
    N Engl J Med. 2018;378:873-4.
    >> Share


  57. MAXMEN A
    Promising HIV vaccines could stall without coordinated research.
    Nature. 2018;555:17-18.
    >> Share


  58. SA E SILVA H, Paulo CO, Duarte F, Abreu RC, et al
    Teaching NeuroImages: Gummatous neurosyphilis: An atypical presentation in a patient with HIV.
    Neurology. 2018;90:e913-e914.
    >> Share

    Pediatr Infect Dis J

  59. IROH TAM PY, Wiens MO, Kabakyenga J, Kiwanuka J, et al
    Pneumonia in HIV-Exposed and Infected Children and Association with Malnutrition.
    Pediatr Infect Dis J. 2018 Mar 2. doi: 10.1097/INF.0000000000001971.
    >> Share

    PLoS Comput Biol

  60. FRYER HR, Wolinsky SM, McLean AR
    Increased T cell trafficking as adjunct therapy for HIV-1.
    PLoS Comput Biol. 2018;14:e1006028.
    >> Share

    PLoS Med

  61. PATEL P, Speight C, Maida A, Loustalot F, et al
    Integrating HIV and hypertension management in low-resource settings: Lessons from Malawi.
    PLoS Med. 2018;15:e1002523.
    >> Share

  62. SLOGROVE AL, Schomaker M, Davies MA, Williams P, et al
    The epidemiology of adolescents living with perinatally acquired HIV: A cross-region global cohort analysis.
    PLoS Med. 2018;15:e1002514.
    >> Share

    PLoS One

  63. GILLET C, Darling KEA, Senn N, Cavassini M, et al
    Targeted versus non-targeted HIV testing offered via electronic questionnaire in a Swiss emergency department: A randomized controlled study.
    PLoS One. 2018;13:e0190767.
    >> Share

  64. JOSEPH DAVEY D, Farley E, Gomba Y, Coates T, et al
    Sexual risk during pregnancy and postpartum periods among HIV-infected and -uninfected South African women: Implications for primary and secondary HIV prevention interventions.
    PLoS One. 2018;13:e0192982.
    >> Share

  65. ANDRADE-SILVA LE, Ferreira-Paim K, Ferreira TB, Vilas-Boas A, et al
    Genotypic analysis of clinical and environmental Cryptococcus neoformans isolates from Brazil reveals the presence of VNB isolates and a correlation with biological factors.
    PLoS One. 2018;13:e0193237.
    >> Share

  66. PAGE-SHIPP L, Lewis JJ, Velen K, Senoge S, et al
    Household point of care CD4 testing and isoniazid preventive therapy initiation in a household TB contact tracing programme in two districts of South Africa.
    PLoS One. 2018;13:e0192089.
    >> Share

  67. NDLOVU Z, Fajardo E, Mbofana E, Maparo T, et al
    Multidisease testing for HIV and TB using the GeneXpert platform: A feasibility study in rural Zimbabwe.
    PLoS One. 2018;13:e0193577.
    >> Share

  68. BULTUM JA, Yigzaw N, Demeke W, Alemayehu M, et al
    Alcohol use disorder and associated factors among human immunodeficiency virus infected patients attending antiretroviral therapy clinic at Bishoftu General Hospital, Oromiya region, Ethiopia.
    PLoS One. 2018;13:e0189312.
    >> Share

  69. BOFFA J, Mayan M, Ndlovu S, Mhlaba T, et al
    The role of agency in the implementation of Isoniazid Preventive Therapy (IPT): Lessons from oMakoti in uMgungundlovu District, South Africa.
    PLoS One. 2018;13:e0193571.
    >> Share

  70. BASTARD M, Sanchez-Padilla E, du Cros P, Khamraev AK, et al
    Outcomes of HIV-infected versus HIV-non-infected patients treated for drug-resistance tuberculosis: Multicenter cohort study.
    PLoS One. 2018;13:e0193491.
    >> Share

  71. RALLON N, Garcia M, Garcia-Samaniego J, Cabello A, et al
    Expression of PD-1 and Tim-3 markers of T-cell exhaustion is associated with CD4 dynamics during the course of untreated and treated HIV infection.
    PLoS One. 2018;13:e0193829.
    >> Share

  72. GRAVES JC, Elyanu P, Schellack CJ, Asire B, et al
    Impact of a Family Clinic Day intervention on paediatric and adolescent appointment adherence and retention in antiretroviral therapy: A cluster randomized controlled trial in Uganda.
    PLoS One. 2018;13:e0192068.
    >> Share

  73. VLOT MC, Grijsen ML, Prins JM, de Jongh RT, et al
    Effect of antiretroviral therapy on bone turnover and bone mineral density in men with primary HIV-1 infection.
    PLoS One. 2018;13:e0193679.
    >> Share

  74. BIRU M, Hallstrom I, Lundqvist P, Jerene D, et al
    Rates and predictors of attrition among children on antiretroviral therapy in Ethiopia: A prospective cohort study.
    PLoS One. 2018;13:e0189777.
    >> Share

    PLoS Pathog

  75. CHITRE AS, Kattah MG, Rosli YY, Pao M, et al
    A20 upregulation during treated HIV disease is associated with intestinal epithelial cell recovery and function.
    PLoS Pathog. 2018;14:e1006806.
    >> Share

  76. MEYERSON NR, Warren CJ, Vieira DASA, Diaz-Griferro F, et al
    Species-specific vulnerability of RanBP2 shaped the evolution of SIV as it transmitted in African apes.
    PLoS Pathog. 2018;14:e1006906.
    >> Share

  77. WAGH K, Seaman MS, Zingg M, Fitzsimons T, et al
    Potential of conventional & bispecific broadly neutralizing antibodies for prevention of HIV-1 subtype A, C & D infections.
    PLoS Pathog. 2018;14:e1006860.
    >> Share

    Proc Natl Acad Sci U S A

    Deciphering how HIV-1 weakens and cracks the bone.
    Proc Natl Acad Sci U S A. 2018 Mar 1. pii: 1801555115.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016